Chongqing Renji Hospital, University of Chinese Academy of Sciences
Chongqing, Chongqing Municipality, 400062, China
NCT Number: NCT04971070
Objective to explore the high risk factors and inducements of consciousness disorder in patients with hypoglycemia, and to conduct a retrospective study.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Chongqing, Chongqing Municipality, 400062, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Symptoms of hypoglycemia such as palpitation, sweating and fatigue were found at the time of treatment. At the same time, the blood glucose of non-diabetic patients was less than 2.8mmol/L, and the blood glucose of diabetic patients was less than 3.9mmol/L
Exclusion criteria
Exclusion criteria
Although there were hypoglycemia symptoms at the time of treatment, the blood glucose of non-diabetic patients was more than 2.8mmol/L, and the blood glucose of diabetic patients was more than 3.9mmol/L.
Observation and follow-up study
Time frame: 2021-2011
Analysis of risk factors of hypoglycemia with disturbance of consciousness
Chongqing Renji Hospital, University of Chinese Academy of Sciences
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05557227
Glucose Metabolism Disorders, Hyperglycemia
Aarhus, Region Midt, Denmark
View Trial DetailsNCT07614139
Carbohydrate Metabolism, Inborn Errors, Congenital Hyperinsulinism
Padova, Italy
View Trial DetailsNCT03078491
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT03859401
Autoimmune Diseases, Behavior
Charlottesville, Virginia, United States
View Trial Details